Aesthetic Medical International Holdings Group Limited (PAIYY) — Capital Reinvestment Ratio

Latest as of December 2024: 0.39x

Aesthetic Medical International Holdings Group Limited (PAIYY) has a Capital Reinvestment Ratio of 0.39x as of December 2024, meaning it reinvests 0% of its operating cash flow ($79.67 Million) in capital expenditures ($30.79 Million). Check Aesthetic Medical International Holdings tangible equity quality to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.39x
Capex / Operating Cash Flow

Operating Cash Flow

$79.67 Million
USD

Capital Expenditures

$30.79 Million
USD

Data as of

Dec 2024
Most recent filing

Aesthetic Medical International Holdings Group Limited Capital Reinvestment Ratio (2021–2024)

This chart tracks Aesthetic Medical International Holdings Group Limited's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see PAIYY cash generation efficiency.

Annual Capital Reinvestment Ratio for Aesthetic Medical International Holdings Group Limited (2021–2024)

Year-by-year Capital Reinvestment Ratio for Aesthetic Medical International Holdings Group Limited from 2021 to 2024. See Aesthetic Medical International Holdings (PAIYY) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2024 0.39x $79.67 Million $30.79 Million ▼ -48.2%
2023 0.75x $74.29 Million $55.46 Million ▲ +14.1%
2021 0.65x $51.09 Million $33.44 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow